NASDAQ:IDXG
Interpace Diagnostics Group Stock News
$1.41
+0 (+0%)
At Close: May 03, 2024
Analysts Are Bullish on These Healthcare Stocks: Momenta Pharma (MNTA), Otonomy (OTIC) - Markets
10:08am, Tuesday, 16'th Jun 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Momenta Pharma
Global Molecular Diagnostics Partnering Terms and Agreements 2014 - 2020 - ResearchAndMarkets.com
12:00am, Tuesday, 16'th Jun 2020
The
Avita Medical (RCEL) Gets a Buy Rating from Oppenheimer - Markets
02:10pm, Monday, 15'th Jun 2020
Oppenheimer analyst Kevin DeGeeter assigned a Buy rating to Avita Medical (RCEL – Research Report) today and set a price
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Global Blood Therapeutics (GBT –
Global Molecular Diagnostics Market - Technologies, Products, Applications and End-Use Sectors to 2022 - ResearchAndMarkets.com
12:00am, Monday, 15'th Jun 2020
The
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on CytoDyn (CYDY
The
Edited Transcript of IDXG earnings conference call or presentation 22-Apr-20 9:00pm GMT
07:48pm, Wednesday, 10'th Jun 2020
Q4 2019 Interpace Biosciences Inc Earnings Call
Strategies for improving Nigeria’s Healthcare practice proposed at the ISN Quality Assurance Summit - Businessday NG
04:15pm, Tuesday, 09'th Jun 2020
Medical laboratory professionals and quality assurance officers have been equipped with strategies necessary for the achievement of quality healthcare in Nigeria at the 5th edition of the ISN Quality
ISN Medical set to host 5th edition of its Quality Assurance Summit - Businessday NG
11:00am, Thursday, 04'th Jun 2020
ISN Medical, the leading supplier of medical diagnostics products and services, has scheduled the fifth edition of its quality assurance summit for Saturday, June 6, 2020. The quarterly event known as
The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis...
